Get the latest tech news
Patients Are Left With Few Options as GLP-1 Copycats Disappear
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had come to rely on compounded versions is increasingly uncertain.
Dustin Olsen, a nutritionist and personal trainer who works with clients taking GLP-1 medications, says he’s already seen people on compounded meds seek out cheaper and more dubiously sourced alternatives online, rather than switching to name brands. In a highly litigious atmosphere, with several major compounding players opting not to test the limits of what’s legally permissible, there will indeed be a significant subset of patients who struggle to find accessible, affordable meds. Halperin understands that people might be tempted to seek out lower-cost alternatives, but she recommends that patients work with a healthcare provider who has experience in treating obesity, even if they can’t get access to a specific medication at the moment.
Or read this on Wired
